Dianthus Therapeutics

United States

Dianthus Therapeutics is a fast-growing biotech company developing best-in-class therapies for severe autoimmune diseases. Their lead antibody, claseprubart (DNTH103), targets the active C1s complement protein with extended half-life and high selectivity for less frequent self-administered subcutaneous injections. Their second candidate, DNTH212, is a bifunctional inhibitor targeting Type 1 IFN suppression and B cell modulation. They operate predominantly as a remote company within the contiguous United States. Visit www.dianthustx.com and follow on LinkedIn.

#Corporate Communications(1)#Internal Communications(1)#Communications Strategy(1)#Executive Communications(1)#Content Strategy(1)#Social Media(1)#Project Management(1)#Storytelling(1)#Employer Branding(1)#Employee Engagement(1)

1 Open Position

Executive Director / Vice President, Corporate and Internal Communications

Remote

Full Time

#Corporate Communications

#Internal Communications

#Communications Strategy

#Executive Communications

#Content Strategy

#Social Media

#Project Management

#Storytelling

#Employer Branding

#Employee Engagement

View all companies